Position in BDTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,878
-$7,128 QoQ
Shares Held
4,638
-33.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BDTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,063,537 across 407 Biotechnology names. BDTX ranks #296 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in BDTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,878 | 4,638 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $17,006 | 6,999 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $1,144 | 302 | Shares | Defined | 2025-11-26 | |
| 2025-03-31 | $31,383 | 20,248 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $40,507 | 18,929 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $76,446 | 17,574 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $74,172 | 15,917 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $48,109 | 9,489 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $2,308,791 | 821,634 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $3,178,762 | 1,107,583 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,454,297 | 1,080,059 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,043 | 552 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $993 | 552 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,423 | 2,026 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,719 | 1,512 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $721,505 | 260,472 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,053,181 | 197,595 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,795,642 | 212,251 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,407,152 | 279,504 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $8,536,122 | 351,860 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $11,501,237 | 358,853 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $6,165,165 | 203,942 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,107,065 | 73,697 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $2,504,629 | 100,386 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||